Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.

MLA

Fabio Farinati, et al. “Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.” PLoS Medicine, vol. 13, no. 4, Apr. 2016, p. e1002006. EBSCOhost, https://doi.org/10.1371/journal.pmed.1002006.

APA

Fabio Farinati, Alessandro Vitale, Gaya Spolverato, Timothy M Pawlik, Teh-la Huo, Yun-Hsuan Lee, Anna Chiara Frigo, Anna Giacomin, Edoardo G Giannini, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, … ITA.LI.CA study group. (2016). Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma. PLoS Medicine, 13(4), e1002006. https://doi.org/10.1371/journal.pmed.1002006

Chicago

Fabio Farinati, Alessandro Vitale, Gaya Spolverato, Timothy M Pawlik, Teh-la Huo, Yun-Hsuan Lee, Anna Chiara Frigo, et al. 2016. “Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.” PLoS Medicine 13 (4): e1002006. doi:10.1371/journal.pmed.1002006.